2021 AD/PD™ Virtual Conference
15:00 - 15:20 | LIVE: PRE CONFERENCE SYMPOSIUM ON PROTECTIVE EFFECTS OF INSULIN AND INCRETINS IN AD/PD 01 | JOIN |
15:20 - 17:30 | LIVE: PRE CONFERENCE SYMPOSIUM ON COMMON FEATURES OF NEURODEGENERATIVE DISEASE: EXPLORING THE BRAIN-EYE CONNECTION AND BEYOND | JOIN |
16:40 -17:00 | LIVE: PRE CONFERENCE SYMPOSIUM ON PROTECTIVE EFFECTS OF INSULIN AND INCRETINS IN AD/PD 02 | JOIN |
18:00 - 18:20 | LIVE: PRE CONFERENCE SYMPOSIUM ON PROTECTIVE EFFECTS OF INSULIN AND INCRETINS IN AD/PD 03 | JOIN |
15:00 - 15:30 | LIVE DISCUSSION - CONGOPHILIC AMYLOID ANGIOPATHY (CAA) VASCULAR DEMENTIA | JOIN |
15:00 - 15:30 | LIVE DISCUSSION - MRI 1 | JOIN |
15:00 - 15:30 | LIVE DISCUSSION - NEUROPATHOLOGY IN AD LBD AND OTHER DEMENTIA | JOIN |
15:00 - 15:30 | LIVE DISCUSSION - VIRUS IMPACT ON NEURODEGENERATIVE DISEASES HERPES SIMPLEX VIRUS COVID-19 | JOIN |
15:00 - 15:30 | Biomarkers in Alzheimer’s Disease Diagnostics: Moving Toward Earlier Diagnosis - SUPPORTED BY Biogen | JOIN |
16:00 - 16:30 | LIVE DISCUSSION - CHOLINERGIC MECHANISMS IN AD AND PD | JOIN |
16:00 - 16:30 | LIVE DISCUSSION - IMAGING AND FLUID BIOMARKERS | JOIN |
16:00 - 16:30 | LIVE DISCUSSION - AUTOPHAGY | JOIN |
16:00 - 16:30 | LIVE DISCUSSION - ABETA STRUCTURE TOXICITY AND NEURODEGENERATION | JOIN |
16:00 - 16:30 | MEET THE PROFESSOR - GUOJUN BU | JOIN |
17:00 - 17:30 | LIVE DISCUSSION - BLOOD-BRAIN BARRIER VASCULAR DAMAGE IN DEMENTIA | JOIN |
17:00 - 17:30 | LIVE DISCUSSION - TRANSLATIONAL TREATMENT STRATEGIES 1 | JOIN |
17:00 - 17:30 | LIVE DISCUSSION - FLUID BIOMARKERS 1 | JOIN |
17:00 - 17:30 | LIVE DISCUSSION - DISEASE MODELLING WITH HUMAN CELLS -TREATMENT STRATEGIES | JOIN |
17:00 - 17:30 | LIVE DISCUSSION - ABETA TARGETING THERAPIES IN AD 1 | JOIN |
17:00 - 17:30 | LIVE DISCUSSION - BACE-1 PRESENILIN GAMMA-SECRETASE AND APP PROCESSING | JOIN |
18:00 -19:00 | FORUM ON IMPACT OF COVID-19 ON NEURODEGENERATIVE DISEASES | JOIN |
19:30 - 20:30 | FORUM ON APPLICATIONS OF NEUROPSYCHOLOGY PET MRI EEG PLASMA AND CSF FOR DIAGNOSIS AND ASSESSMENT OF TREATMENT EFFECTS | JOIN |
14:00 -15:30 | The early diagnosis of Alzheimer’s disease: discovering complex clinical and pathological features - SUPPORTED BY Biogen | JOIN |
15:00 - 16:00 | MEET THE PROFESSOR - RUDOLPH TANZI | JOIN |
15:30 - 16:00 | LIVE DISCUSSION - TAU-TARGETED TREATMENT STRATEGIES | JOIN |
15:30 - 16:00 | LIVE DISCUSSION - TREM2 MICROGLIA | JOIN |
15:30 - 16:00 | LIVE DISCUSSION - TREATMENT STRATEGIES FOR PD AND DLB | JOIN |
15:30 - 16:00 | LIVE DISCUSSION - AD DIAGNOSIS EARLY PHASE AD CLINICAL TRIALS (1) | JOIN |
16:30 - 17:00 | Digital Cognitive Phenotyping in Neurodegenerative Disease: Impact of Digital on Neurology Practice - SUPPORTED BY nQ Medical | JOIN |
16:30 - 17:00 | LIVE DISCUSSION - IMAGING AND BIOMARKERS IN PD LBD | JOIN |
16:30 - 17:00 | LIVE DISCUSSION - SYNAPTIC DAMAGE AND NEURONAL PLASTICITY | JOIN |
16:30 - 17:00 | LIVE DISCUSSION - ALPHA-SYNUCLEIN AND DISEASE MECHANISMS (1) | JOIN |
16:30 - 17:00 | LIVE DISCUSSION - TDP-43 IN ALS AND FTD | JOIN |
17:30 - 18:00 | LIVE DISCUSSION - GENETICS OF NEURODEGENERATION 1 | JOIN |
17:30 - 18:00 | LIVE DISCUSSION - TAU PATHOLOGY AND THERAPEUTIC STRATEGIES 1 | JOIN |
17:30 - 18:00 | LIVE DISCUSSION - TREM2 AND TREM 1 (2) | JOIN |
17:30 - 18:00 | LIVE DISCUSSION - C9ORF72 AND PROGRANULIN IN ALS AND FTD | JOIN |
17:30 - 18:00 | LIVE DISCUSSION - ORGANOIDS AND ANIMAL MODELS IN AD PD | JOIN |
18:30 - 19:30 | FORUM ON PHASE I-II CLINICAL TRIALS IN ALZHEIMER’S DISEASE | JOIN |
10:00 -12:10 | Using single cell and spatial technologies to untangle the complexities of neurodegenerative disease - SUPPORTED BY 10x Genomics | JOIN |
12:00 - 13:00 | Parkinson’s. Time for meaningful change: looking back at symptomatic therapy and moving towards disease modification - SUPPORTED BY Roche | JOIN |
14:00 - 15:00 | LIVE PANEL: Alzheimer’s disease perspectives from around the world - SUPPORTED BY Roche | JOIN |
15:30 - 16:00 | LIVE DISCUSSION - AD ANIMAL MODELS AND MECHANISTIC ASPECTS (1) | JOIN |
15:30 - 16:00 | LIVE DISCUSSION - AMYLOID AND TAU PET IMAGING | JOIN |
15:30 - 16:00 | LIVE DISCUSSION - RNA | JOIN |
15:30 -16:00 | LIVE DISCUSSION - AD DIAGNOSIS EARLY PHASE AD CLINICAL TRIALS (2) | JOIN |
16:00 -17:00 | Gamma sensory stimulation a novel AD therapeutic intervention: initial safety efficacy and biomarker changes from two prospective clinical studies - SUPPORTED BY Cognito Therapeutics | JOIN |
16:30 -17:00 | LIVE DISCUSSION - TAU PROPAGATION AND CELLULAR INTERACTIONS | JOIN |
16:30 -17:00 | LIVE DISCUSSION - METABOLIC PATTERNS AND CHANGES IN AD AND LBD | JOIN |
16:30 -17:00 | MEET THE PROFESSOR - ANGELA GENGE | JOIN |
16:30 -17:00 | MEET THE PROFESSOR - CHRISTIAN HAAS | JOIN |
16:30 -17:00 | LIVE DISCUSSION - AMYLOID TAU AND SYNAPSE PET IMAGING | JOIN |
16:30 -17:00 | LIVE DISCUSSION - GENETICS OF NEURODEGENERATION 2 | JOIN |
16:30 -17:00 | LIVE DISCUSSION - MOLECULAR MECHANISMS IN PROTEINOPATHY | JOIN |
17:30 - 18:00 | LIVE DISCUSSION - NEUROINFLAMMATION MICROGLIA AND ASTROCYTES | JOIN |
17:30 - 18:00 | LIVE DISCUSSION - MRI 2 | JOIN |
17:30 - 18:00 | LIVE DISCUSSION - COGNITIVE DYSFUNCTIONS PATHOLOGY AND TREATMENT APPROACHES IN PD HD | JOIN |
17:30 - 18:00 | LIVE DISCUSSION - PATHWAYS AND TARGETS IN MODELS OF SEEDED AGGREGATION | JOIN |
17:30 - 18:00 | LIVE DISCUSSION - BIOMARKERS IMAGING IN AD PD AND LBD | JOIN |
18:30 -19:30 | FORUM ON TRANSLATIONAL DRUG DISCOVERY IN PD/ LBD PHASE I-III - RECENT UPDATES | JOIN |